105 related articles for article (PubMed ID: 12960592)
1. 99mTc sestamibi and 99mTc tetrofosmin scintigraphy for predicting resistance to chemotherapy: a critical review of clinical data.
Van de Wiele C; Rottey S; Goethals I; Buscombe J; Van Belle S; De Vos F; Dierckx RA
Nucl Med Commun; 2003 Sep; 24(9):945-50. PubMed ID: 12960592
[No Abstract] [Full Text] [Related]
2. Scintigraphic detection of multidrug resistance in cancer.
Del Vecchio S; Ciarmiello A; Salvatore M
Cancer Biother Radiopharm; 2000 Aug; 15(4):327-37. PubMed ID: 11041017
[TBL] [Abstract][Full Text] [Related]
3. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
4. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA
Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920
[TBL] [Abstract][Full Text] [Related]
5. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic prediction of response to chemotherapy in patients with breast cancer: Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography.
Takeuchi N; Fukumoto M; Nishioka A; Akagi N; Murata Y; Takeuchi S; Ogawa Y; Yoshida S
Int J Oncol; 2002 Jan; 20(1):53-8. PubMed ID: 11743642
[TBL] [Abstract][Full Text] [Related]
7. Tetrofosmin thyroid scintigraphy.
Klain M; Cuocolo A; Salvatore M; Maurea S
Eur J Nucl Med; 1998 Jul; 25(7):816. PubMed ID: 9741994
[No Abstract] [Full Text] [Related]
8. 99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.
Bakker M; van der Graaf WT; Piers DA; Franssen EJ; Groen HJ; Smit EF; Kool W; Hollema H; Müller EA; De Vries EG
Anticancer Res; 1999; 19(3B):2349-53. PubMed ID: 10472354
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of chemotherapy response in patients with small cell lung cancer using Technetium-99m-tetrofosmin.
Kao CH; Ho YJ; Shen YY; Lee JK
Anticancer Res; 1999; 19(3B):2311-5. PubMed ID: 10472350
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
12. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF
J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779
[TBL] [Abstract][Full Text] [Related]
13. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
14. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients.
Spanu A; Ginesu F; Pirina P; Schillaci O; Farris A; Chessa F; Madeddu G; Falchi A; Madeddu G
Oncol Rep; 2003; 10(6):1701-7. PubMed ID: 14534682
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo.
Luker GD; Fracasso PM; Dobkin J; Piwnica-Worms D
J Nucl Med; 1997 Mar; 38(3):369-72. PubMed ID: 9074520
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer].
Schmidt E; Kett K; Anga B; Bódis J; Zámbó K
Orv Hetil; 2003 Apr; 144(17):787-92. PubMed ID: 12762063
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors.
Muzzammil T; Moore MJ; Ballinger JR
Cancer Biother Radiopharm; 2000 Aug; 15(4):339-46. PubMed ID: 11041018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]